| ■ 영문 제목 : Global Mebendazole Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K00101 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 96 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦5,124,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,686,000 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦10,248,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 메벤다졸의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (정제, 경구 현탁액)와 용도별 시장규모 (2세 이하, 2세 이상) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 메벤다졸 시장 점유율 - 지역별 메벤다졸 시장규모 - 주요지역의 종류별 시장규모 (정제, 경구 현탁액) - 주요지역의 용도별 시장규모 (2세 이하, 2세 이상) - 미주의 메벤다졸 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 메벤다졸 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 메벤다졸 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 메벤다졸 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 메벤다졸 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Johnson & Johnson, Amneal Pharmaceuticals, Cadila Pharmaceuticals, Eipico, Esteve Pharmaceuticals, Tenry - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Mebendazole will have significant change from previous year. By the most conservative estimates of global Mebendazole market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 108.9 million in 2020. Over the next five years the Mebendazole market will register a 5.8% CAGR in terms of revenue, the global market size will reach US$ 136.5 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Mebendazole market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Tablet
Oral Suspension
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Below 2 Years Old
Above 2 Years Old
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Johnson & Johnson
Amneal Pharmaceuticals
Cadila Pharmaceuticals
Eipico
Esteve Pharmaceuticals
Tenry
1 Scope of the Report 2 Executive Summary 3 Global Mebendazole by Company 4 Mebendazole by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global Mebendazole Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. Mebendazole Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Tablet Table 3. Major Players of Oral Suspension Table 4. Global Mebendazole Sales by Type (2016-2021) & (K Units) Table 5. Global Mebendazole Sales Market Share by Type (2016-2021) Table 6. Global Mebendazole Revenue by Type (2016-2021) & ($ million) Table 7. Global Mebendazole Revenue Market Share by Type (2016-2021) Table 8. Global Mebendazole Sale Price by Type (2016-2021) Table 9. Global Mebendazole Sales by Application (2016-2021) & (K Units) Table 10. Global Mebendazole Sales Market Share by Application (2016-2021) Table 11. Global Mebendazole Value by Application (2016-2021) Table 12. Global Mebendazole Revenue Market Share by Application (2016-2021) Table 13. Global Mebendazole Sale Price by Application (2016-2021) Table 14. Global Mebendazole Sales by Company (2019-2021) & (K Units) Table 15. Global Mebendazole Sales Market Share by Company (2019-2021) Table 16. Global Mebendazole Revenue by Company (2019-2021) ($ Millions) Table 17. Global Mebendazole Revenue Market Share by Company (2019-2021) Table 18. Global Mebendazole Sale Price by Company (2019-2021) Table 19. Key Manufacturers Mebendazole Producing Area Distribution and Sales Area Table 20. Players Mebendazole Products Offered Table 21. Mebendazole Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global Mebendazole Sales by Region (2016-2021) (K Units) Table 25. Global Mebendazole Sales Market Share by Region (2016-2021) Table 26. Global Mebendazole Revenue by Region (2016-2021) & ($ Millions) Table 27. Global Mebendazole Revenue Market Share by Region (2016-2021) Table 28. Americas Mebendazole Sales by Country (2016-2021) & (K Units) Table 29. Americas Mebendazole Sales Market Share by Country (2016-2021) Table 30. Americas Mebendazole Revenue by Country (2016-2021) & ($ Millions) Table 31. Americas Mebendazole Revenue Market Share by Country (2016-2021) Table 32. Americas Mebendazole Sales by Type (2016-2021) & (K Units) Table 33. Americas Mebendazole Sales Market Share by Type (2016-2021) Table 34. Americas Mebendazole Sales by Application (2016-2021) & (K Units) Table 35. Americas Mebendazole Sales Market Share by Application (2016-2021) Table 36. APAC Mebendazole Sales by Region (2016-2021) & (K Units) Table 37. APAC Mebendazole Sales Market Share by Region (2016-2021) Table 38. APAC Mebendazole Revenue by Region (2016-2021) & ($ Millions) Table 39. APAC Mebendazole Revenue Market Share by Region (2016-2021) Table 40. APAC Mebendazole Sales by Type (2016-2021) & (K Units) Table 41. APAC Mebendazole Sales Market Share by Type (2016-2021) Table 42. APAC Mebendazole Sales by Application (2016-2021) & (K Units) Table 43. APAC Mebendazole Sales Market Share by Application (2016-2021) Table 44. Europe Mebendazole Sales by Country (2016-2021) & (K Units) Table 45. Europe Mebendazole Sales Market Share by Country (2016-2021) Table 46. Europe Mebendazole Revenue by Country (2016-2021) & ($ Millions) Table 47. Europe Mebendazole Revenue Market Share by Country (2016-2021) Table 48. Europe Mebendazole Sales by Type (2016-2021) & (K Units) Table 49. Europe Mebendazole Sales Market Share by Type (2016-2021) Table 50. Europe Mebendazole Sales by Application (2016-2021) & (K Units) Table 51. Europe Mebendazole Sales Market Share by Application (2016-2021) Table 52. Middle East & Africa Mebendazole Sales by Country (2016-2021) & (K Units) Table 53. Middle East & Africa Mebendazole Sales Market Share by Country (2016-2021) Table 54. Middle East & Africa Mebendazole Revenue by Country (2016-2021) & ($ Millions) Table 55. Middle East & Africa Mebendazole Revenue Market Share by Country (2016-2021) Table 56. Middle East & Africa Mebendazole Sales by Type (2016-2021) & (K Units) Table 57. Middle East & Africa Mebendazole Sales Market Share by Type (2016-2021) Table 58. Middle East & Africa Mebendazole Sales by Application (2016-2021) & (K Units) Table 59. Middle East & Africa Mebendazole Sales Market Share by Application (2016-2021) Table 60. Key and Potential Regions of Mebendazole Table 61. Key Application and Potential Industries of Mebendazole Table 62. Key Challenges of Mebendazole Table 63. Key Trends of Mebendazole Table 64. Mebendazole Distributors List Table 65. Mebendazole Customer List Table 66. Global Mebendazole Sales Forecast by Region (2021-2026) & (K Units) Table 67. Global Mebendazole Consumption Market Forecast by Region Table 68. Global Mebendazole Revenue Forecast by Region (2021-2026) & ($ millions) Table 69. Global Mebendazole Revenue Market Share Forecast by Region (2021-2026) Table 70. Americas Mebendazole Sales Forecast by Country (2021-2026) & (K Units) Table 71. Americas Mebendazole Revenue Forecast by Country (2021-2026) & ($ millions) Table 72. APAC Mebendazole Sales Forecast by Region (2021-2026) & (K Units) Table 73. APAC Mebendazole Revenue Forecast by Region (2021-2026) & ($ millions) Table 74. Europe Mebendazole Sales Forecast by Country (2021-2026) & (K Units) Table 75. Europe Mebendazole Revenue Forecast by Country (2021-2026) & ($ millions) Table 76. Middle East & Africa Mebendazole Sales Forecast by Country (2021-2026) & (K Units) Table 77. Middle East & Africa Mebendazole Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Global Mebendazole Sales Forecast by Type (2021-2026) & (K Units) Table 79. Global Mebendazole Sales Market Share Forecast by Type (2021-2026) Table 80. Global Mebendazole Revenue Forecast by Type (2021-2026) & ($ Millions) Table 81. Global Mebendazole Revenue Market Share Forecast by Type (2021-2026) Table 82. Global Mebendazole Sales Forecast by Application (2021-2026) & (K Units) Table 83. Global Mebendazole Sales Market Share Forecast by Application (2021-2026) Table 84. Global Mebendazole Revenue Forecast by Application (2021-2026) & ($ Millions) Table 85. Global Mebendazole Revenue Market Share Forecast by Application (2021-2026) Table 86. Johnson & Johnson Basic Information, Mebendazole Manufacturing Base, Sales Area and Its Competitors Table 87. Johnson & Johnson Mebendazole Product Offered Table 88. Johnson & Johnson Mebendazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 89. Johnson & Johnson Main Business Table 90. Johnson & Johnson Latest Developments Table 91. Amneal Pharmaceuticals Basic Information, Mebendazole Manufacturing Base, Sales Area and Its Competitors Table 92. Amneal Pharmaceuticals Mebendazole Product Offered Table 93. Amneal Pharmaceuticals Mebendazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 94. Amneal Pharmaceuticals Main Business Table 95. Amneal Pharmaceuticals Latest Developments Table 96. Cadila Pharmaceuticals Basic Information, Mebendazole Manufacturing Base, Sales Area and Its Competitors Table 97. Cadila Pharmaceuticals Mebendazole Product Offered Table 98. Cadila Pharmaceuticals Mebendazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 99. Cadila Pharmaceuticals Main Business Table 100. Cadila Pharmaceuticals Latest Developments Table 101. Eipico Basic Information, Mebendazole Manufacturing Base, Sales Area and Its Competitors Table 102. Eipico Mebendazole Product Offered Table 103. Eipico Mebendazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 104. Eipico Main Business Table 105. Eipico Latest Developments Table 106. Esteve Pharmaceuticals Basic Information, Mebendazole Manufacturing Base, Sales Area and Its Competitors Table 107. Esteve Pharmaceuticals Mebendazole Product Offered Table 108. Esteve Pharmaceuticals Mebendazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 109. Esteve Pharmaceuticals Main Business Table 110. Esteve Pharmaceuticals Latest Developments Table 111. Tenry Basic Information, Mebendazole Manufacturing Base, Sales Area and Its Competitors Table 112. Tenry Mebendazole Product Offered Table 113. Tenry Mebendazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 114. Tenry Main Business Table 115. Tenry Latest Developments List of Figures Figure 1. Picture of Mebendazole Figure 2. Mebendazole Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Mebendazole Sales Growth Rate 2016-2026 (K Units) Figure 7. Global Mebendazole Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Mebendazole Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Tablet Figure 10. Product Picture of Oral Suspension Figure 11. Global Mebendazole Sales Market Share by Type in 2020 Figure 12. Global Mebendazole Revenue Market Share by Type (2016-2021) Figure 13. Mebendazole Consumed in Below 2 Years Old Figure 14. Global Mebendazole Market: Below 2 Years Old (2016-2021) & (K Units) Figure 15. Mebendazole Consumed in Above 2 Years Old Figure 16. Global Mebendazole Market: Above 2 Years Old (2016-2021) & (K Units) Figure 17. Global Mebendazole Sales Market Share by Application (2016-2021) Figure 18. Global Mebendazole Revenue Market Share by Application in 2020 Figure 19. Mebendazole Revenue Market by Company in 2020 ($ Million) Figure 20. Global Mebendazole Revenue Market Share by Company in 2020 Figure 21. Global Mebendazole Sales Market Share by Regions (2016-2021) Figure 22. Global Mebendazole Revenue Market Share by Region in 2020 Figure 23. Americas Mebendazole Sales 2016-2021 (K Units) Figure 24. Americas Mebendazole Revenue 2016-2021 ($ Millions) Figure 25. APAC Mebendazole Sales 2016-2021 (K Units) Figure 26. APAC Mebendazole Revenue 2016-2021 ($ Millions) Figure 27. Europe Mebendazole Sales 2016-2021 (K Units) Figure 28. Europe Mebendazole Revenue 2016-2021 ($ Millions) Figure 29. Middle East & Africa Mebendazole Sales 2016-2021 (K Units) Figure 30. Middle East & Africa Mebendazole Revenue 2016-2021 ($ Millions) Figure 31. Americas Mebendazole Sales Market Share by Country in 2020 Figure 32. Americas Mebendazole Revenue Market Share by Country in 2020 Figure 33. Americas Mebendazole Sales Market Share by Type in 2020 Figure 34. Americas Mebendazole Sales Market Share by Application in 2020 Figure 35. United States Mebendazole Revenue Growth 2016-2021 ($ Millions) Figure 36. Canada Mebendazole Revenue Growth 2016-2021 ($ Millions) Figure 37. Mexico Mebendazole Revenue Growth 2016-2021 ($ Millions) Figure 38. Brazil Mebendazole Revenue Growth 2016-2021 ($ Millions) Figure 39. APAC Mebendazole Sales Market Share by Region in 2020 Figure 40. APAC Mebendazole Revenue Market Share by Regions in 2020 Figure 41. APAC Mebendazole Sales Market Share by Type in 2020 Figure 42. APAC Mebendazole Sales Market Share by Application in 2020 Figure 43. China Mebendazole Revenue Growth 2016-2021 ($ Millions) Figure 44. Japan Mebendazole Revenue Growth 2016-2021 ($ Millions) Figure 45. Korea Mebendazole Revenue Growth 2016-2021 ($ Millions) Figure 46. Southeast Asia Mebendazole Revenue Growth 2016-2021 ($ Millions) Figure 47. India Mebendazole Revenue Growth 2016-2021 ($ Millions) Figure 48. Australia Mebendazole Revenue Growth 2016-2021 ($ Millions) Figure 49. Europe Mebendazole Sales Market Share by Country in 2020 Figure 50. Europe Mebendazole Revenue Market Share by Country in 2020 Figure 51. Europe Mebendazole Sales Market Share by Type in 2020 Figure 52. Europe Mebendazole Sales Market Share by Application in 2020 Figure 53. Germany Mebendazole Revenue Growth 2016-2021 ($ Millions) Figure 54. France Mebendazole Revenue Growth 2016-2021 ($ Millions) Figure 55. UK Mebendazole Revenue Growth 2016-2021 ($ Millions) Figure 56. Italy Mebendazole Revenue Growth 2016-2021 ($ Millions) Figure 57. Russia Mebendazole Revenue Growth 2016-2021 ($ Millions) Figure 58. Middle East & Africa Mebendazole Sales Market Share by Country in 2020 Figure 59. Middle East & Africa Mebendazole Revenue Market Share by Country in 2020 Figure 60. Middle East & Africa Mebendazole Sales Market Share by Type in 2020 Figure 61. Middle East & Africa Mebendazole Sales Market Share by Application in 2020 Figure 62. Egypt Mebendazole Revenue Growth 2016-2021 ($ Millions) Figure 63. South Africa Mebendazole Revenue Growth 2016-2021 ($ Millions) Figure 64. Israel Mebendazole Revenue Growth 2016-2021 ($ Millions) Figure 65. Turkey Mebendazole Revenue Growth 2016-2021 ($ Millions) Figure 66. GCC Country Mebendazole Revenue Growth 2016-2021 ($ Millions) Figure 67. Channels of Distribution Figure 68. Distributors Profiles |
| ※본 조사보고서 [세계의 메벤다졸 시장예측 2021년-2026년] (코드 : LPI-2201K00101) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 메벤다졸 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |